{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:34:28Z","timestamp":1794314068455,"version":"4.9.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>Gastrointestinal malignant melanoma is a rare mucosal melanoma (MM). Other MM include the respiratory and the genitourinary tract. All mucosal melanomas have a poor prognosis when compared to cutaneous melanomas. Ano-rectal melanomas are by far the most common and most studied gastrointestinal MM. Large-scale clinical data is lacking due to the rarity of the disease. We aim to analyze epidemiology and survival of the Gastrointestinal (G.I.) MM over 45\u00a0years using a national database.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The Surveillance, Epidemiology and End Results (SEER) database was queried to identify patients with biopsy-proven G.I. Melanomas. We selected tumor site, intervention, and survival information for oncology codes as per the international classification of diseases. Survival analysis was performed using the SPSS v 27 \u00ae IBM software.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 1105 biopsy-proven confirmed cases of primary G.I. melanoma's, 191 (17.3%) received chemotherapy (C.T.), 202 (18.3%) received radiotherapy (R.T.), 63 (5.7%) received both C.T and R.T., while 684 (61.9%) of the population received surgery alone or combined with C.T. and\/or R.T. Statistically significant improvement in survival was noted in all treatment strategies that utilized surgery and also when site-specific MM cohorts underwent a surgical approach with or without C.T and\/or R.T.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This is the most extensive study reporting epidemiological and survival data of treatment strategy outcomes of primary G.I. mucosal melanoma elucidating best overall survival with a management strategy involving surgical intervention.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12876-022-02254-5","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T17:02:39Z","timestamp":1649523759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Epidemiology and outcomes of gastrointestinal mucosal melanomas: a national database analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Niraj James","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Aloysius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldrin","family":"Bhanat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Aswath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savio","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shou-Jiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,9]]},"reference":[{"issue":"8","key":"2254_CR1","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","volume":"83","author":"AE Chang","year":"1998","unstructured":"Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83(8):1664\u201378.","journal-title":"Cancer"},{"key":"2254_CR2","doi-asserted-by":"crossref","unstructured":"Kohoutova D, Worku D, Aziz H, Teare J, Weir J, Larkin J. Malignant melanoma of the gastrointestinal tract: symptoms, diagnosis, and current treatment options. Cells. 2021;10(2).","DOI":"10.3390\/cells10020327"},{"issue":"4","key":"2254_CR3","first-page":"365","volume":"16","author":"A Amar","year":"1992","unstructured":"Amar A, Jougon J, Edouard A, Laban P, Marry JP, Hillion G. Primary malignant melanoma of the small intestine. Gastroenterol Clin Biol. 1992;16(4):365\u20137.","journal-title":"Gastroenterol Clin Biol"},{"issue":"6","key":"2254_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.21037\/atm.2016.03.29","volume":"4","author":"AV Hadjinicolaou","year":"2016","unstructured":"Hadjinicolaou AV, Hadjittofi C, Athanasopoulos PG, Shah R, Ala AA. Primary small bowel melanomas: fact or myth? Ann Transl Med. 2016;4(6):113.","journal-title":"Ann Transl Med"},{"issue":"4","key":"2254_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jso.2930100402","volume":"10","author":"MM Krausz","year":"1978","unstructured":"Krausz MM, Ariel I, Behar AJ. Primary malignant melanoma of the small intestine and the APUD cell concept. J Surg Oncol. 1978;10(4):283\u20138.","journal-title":"J Surg Oncol"},{"issue":"5","key":"2254_CR6","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/1097-0142(1967)20:5<632::AID-CNCR2820200510>3.0.CO;2-7","volume":"20","author":"Y Mishima","year":"1967","unstructured":"Mishima Y. Melanocytic and nevocytic malignant melanomas. Cellular and subcellular differentiation. Cancer. 1967;20(5):632\u201349.","journal-title":"Cancer"},{"issue":"7","key":"2254_CR7","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/cncr.21334","volume":"104","author":"A Burgi","year":"2005","unstructured":"Burgi A, Brodine S, Wegner S, Milazzo M, Wallace MR, Spooner K, Blazes DL, Agan BK, Armstrong A, Fraser S, et al. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer. 2005;104(7):1505\u201311.","journal-title":"Cancer"},{"issue":"9","key":"2254_CR8","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/BF02238576","volume":"42","author":"B Cagir","year":"1999","unstructured":"Cagir B, Whiteford MH, Topham A, Rakinic J, Fry RD. Changing epidemiology of anorectal melanoma. Dis Colon Rectum. 1999;42(9):1203\u20138.","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"2254_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/CMR.0b013e32831ef262","volume":"19","author":"TR Cote","year":"2009","unstructured":"Cote TR, Sobin LH. Primary melanomas of the esophagus and anorectum: epidemiologic comparison with melanoma of the skin. Melanoma Res. 2009;19(1):58\u201360.","journal-title":"Melanoma Res"},{"issue":"4","key":"2254_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0748-7983(98)80011-5","volume":"24","author":"M Pandey","year":"1998","unstructured":"Pandey M, Mathew A, Abraham EK, Ahamed IM, Nair KM. Primary malignant melanoma of the mucous membranes. Eur J Surg Oncol. 1998;24(4):303\u20137.","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"2254_CR11","first-page":"561","volume":"179","author":"CM Sutherland","year":"1994","unstructured":"Sutherland CM, Chmiel JS, Henson DE, Winchester DP. Patient characteristics, methods of diagnosis, and treatment of mucous membrane melanoma in the United States of America. J Am Coll Surg. 1994;179(5):561\u20136.","journal-title":"J Am Coll Surg"},{"issue":"12","key":"2254_CR12","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1002\/hed.20901","volume":"30","author":"M Meleti","year":"2008","unstructured":"Meleti M, Leemans CR, de Bree R, Vescovi P, Sesenna E, van der Waal I. Head and neck mucosal melanoma: experience with 42 patients, with emphasis on the role of postoperative radiotherapy. Head Neck. 2008;30(12):1543\u201351.","journal-title":"Head Neck"},{"issue":"7","key":"2254_CR13","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1002\/1097-0142(19850401)55:7<1543::AID-CNCR2820550722>3.0.CO;2-F","volume":"55","author":"RP Rapini","year":"1985","unstructured":"Rapini RP, Golitz LE, Greer RO Jr, Krekorian EA, Poulson T. Primary malignant melanoma of the oral cavity. A review of 177 cases. Cancer. 1985;55(7):1543\u201351.","journal-title":"Cancer"},{"issue":"3","key":"2254_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.6004\/jnccn.2012.0034","volume":"10","author":"RD Carvajal","year":"2012","unstructured":"Carvajal RD, Spencer SA, Lydiatt W. Mucosal melanoma: a clinically and biologically unique disease entity. J Natl Compr Canc Netw. 2012;10(3):345\u201356.","journal-title":"J Natl Compr Canc Netw"},{"issue":"7","key":"2254_CR15","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1634\/theoncologist.2015-0522","volume":"21","author":"D Kuk","year":"2016","unstructured":"Kuk D, Shoushtari AN, Barker CA, Panageas KS, Munhoz RR, Momtaz P, Ariyan CE, Brady MS, Coit DG, Bogatch K, et al. Prognosis of mucosal, uveal, acral, nonacral cutaneous, and unknown primary melanoma from the time of first metastasis. Oncologist. 2016;21(7):848\u201354.","journal-title":"Oncologist"},{"issue":"2","key":"2254_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/00001622-200003000-00014","volume":"12","author":"LM Schuchter","year":"2000","unstructured":"Schuchter LM, Green R, Fraker D. Primary and metastatic diseases in malignant melanoma of the gastrointestinal tract. Curr Opin Oncol. 2000;12(2):181\u20135.","journal-title":"Curr Opin Oncol"},{"issue":"6","key":"2254_CR17","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1097\/01.sla.0000225114.56565.f9","volume":"244","author":"JJ Yeh","year":"2006","unstructured":"Yeh JJ, Shia J, Hwu WJ, Busam KJ, Paty PB, Guillem JG, Coit DG, Wong WD, Weiser MR. The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg. 2006;244(6):1012\u20137.","journal-title":"Ann Surg"},{"key":"2254_CR18","doi-asserted-by":"crossref","unstructured":"Dumaz N, Jouenne F, Delyon J, Mourah S, Bensussan A, Lebbe C. Atypical BRAF and NRAS mutations in mucosal melanoma. Cancers (Basel) 2019;11(8).","DOI":"10.3390\/cancers11081133"},{"issue":"1","key":"2254_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/bjs.6784","volume":"97","author":"PJ Nilsson","year":"2010","unstructured":"Nilsson PJ, Ragnarsson-Olding BK. Importance of clear resection margins in anorectal malignant melanoma. Br J Surg. 2010;97(1):98\u2013103.","journal-title":"Br J Surg"},{"issue":"2","key":"2254_CR20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1288\/00005537-199402000-00001","volume":"104","author":"SP Lee","year":"1994","unstructured":"Lee SP, Shimizu KT, Tran LM, Juillard G, Calcaterra TC. Mucosal melanoma of the head and neck: the impact of local control on survival. Laryngoscope. 1994;104(2):121\u20136.","journal-title":"Laryngoscope"},{"issue":"4","key":"2254_CR21","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.amjsurg.2005.01.022","volume":"189","author":"JT Droesch","year":"2005","unstructured":"Droesch JT, Flum DR, Mann GN. Wide local excision or abdominoperineal resection as the initial treatment for anorectal melanoma? Am J Surg. 2005;189(4):446\u20139.","journal-title":"Am J Surg"},{"issue":"1","key":"2254_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1245\/s10434-009-0705-0","volume":"17","author":"DM Iddings","year":"2010","unstructured":"Iddings DM, Fleisig AJ, Chen SL, Faries MB, Morton DL. Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients? Ann Surg Oncol. 2010;17(1):40\u20134.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"2254_CR23","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jaad.2006.06.017","volume":"56","author":"RJ Patrick","year":"2007","unstructured":"Patrick RJ, Fenske NA, Messina JL. Primary mucosal melanoma. J Am Acad Dermatol. 2007;56(5):828\u201334.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"2254_CR24","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1007\/s00432-016-2245-x","volume":"142","author":"L Tchelebi","year":"2016","unstructured":"Tchelebi L, Guirguis A, Ashamalla H. Rectal melanoma: epidemiology, prognosis, and role of adjuvant radiation therapy. J Cancer Res Clin Oncol. 2016;142(12):2569\u201375.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"16","key":"2254_CR25","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1158\/1078-0432.CCR-13-0739","volume":"19","author":"B Lian","year":"2013","unstructured":"Lian B, Si L, Cui C, Chi Z, Sheng X, Mao L, Li S, Kong Y, Tang B, Guo J. Phase II randomized trial comparing high-dose IFN-alpha2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma. Clin Cancer Res. 2013;19(16):4488\u201398.","journal-title":"Clin Cancer Res"},{"key":"2254_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejca.2020.07.017","volume":"138","author":"P Nenclares","year":"2020","unstructured":"Nenclares P, Ap Dafydd D, Bagwan I, Begg D, Kerawala C, King E, Lingley K, Paleri V, Paterson G, Payne M, et al. Head and neck mucosal melanoma: the United Kingdom national guidelines. Eur J Cancer. 2020;138:11\u20138.","journal-title":"Eur J Cancer"},{"issue":"11","key":"2254_CR27","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1002\/hed.26849","volume":"43","author":"M Edmond","year":"2021","unstructured":"Edmond M, Nenclares P, Harrington K, Ap Dafydd D, Bagwan I, Begg D, Lingley K, Patterson G, Payne M, Steven N, et al. What is the role of the surgeon in the management of head and neck mucosal melanoma in the immunotherapy era? Head Neck. 2021;43(11):3498\u2013503.","journal-title":"Head Neck"},{"issue":"2","key":"2254_CR28","first-page":"e13408","volume":"13","author":"HR Syed","year":"2021","unstructured":"Syed HR, Shekar S, Aravantagi A. Melanoma and the Gastrointestinal (GI) Tract: Maintaining a High Index of Suspicion. Cureus. 2021;13(2):e13408.","journal-title":"Cureus"},{"issue":"3","key":"2254_CR29","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1007\/s12029-020-00545-2","volume":"52","author":"HD Phan","year":"2021","unstructured":"Phan HD, Tan HT, Tabibian JH. Bleeding beyond the line: anorectal melanoma as a cause of lower gastrointestinal bleeding. J Gastrointest Cancer. 2021;52(3):1090\u20132.","journal-title":"J Gastrointest Cancer"},{"key":"2254_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jss.2020.11.048","volume":"260","author":"AR Kahl","year":"2021","unstructured":"Kahl AR, Gao X, Chioreso C, Goffredo P, Hassan I, Charlton ME, Lin C. Presentation, management, and prognosis of primary gastrointestinal melanoma: a population-based study. J Surg Res. 2021;260:46\u201355.","journal-title":"J Surg Res"},{"key":"2254_CR31","doi-asserted-by":"crossref","unstructured":"Eng JY, Tahkin S, Yaacob H, Yunus NH, Sidek A, Wong MP. Multiple gastrointestinal melanoma causing small bowel intussusception. Ann Coloproctol 2021.","DOI":"10.3393\/ac.2021.00143.0020"},{"issue":"2","key":"2254_CR32","first-page":"231","volume":"75","author":"M Endo","year":"2021","unstructured":"Endo M, Yano S, Asano H, Takeda S, Hamada Y, Kondo Y, Kuroda S, Shigeyasu K, Kikuchi S, Tanaka T, et al. Long-term survival with a rare advanced primary gastrointestinal malignant melanoma treated with laparoscopic surgery\/immune checkpoint inhibitor. Acta Med Okayama. 2021;75(2):231\u20138.","journal-title":"Acta Med Okayama"},{"issue":"9","key":"2254_CR33","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1308\/rcsann.2020.7139","volume":"103","author":"K Dalci","year":"2021","unstructured":"Dalci K, Teke Z, Atar C, Doran F. Primary gastric melanoma presenting with recurrent upper gastrointestinal bleeding. Ann R Coll Surg Engl. 2021;103(9):e282\u20134.","journal-title":"Ann R Coll Surg Engl"},{"issue":"2","key":"2254_CR34","doi-asserted-by":"publisher","first-page":"967","DOI":"10.21873\/anticanres.14850","volume":"41","author":"H Badakhshi","year":"2021","unstructured":"Badakhshi H, Wang ZM, Li RJ, Ismail M, Kaul D. Survival and prognostic nomogram for primary gastrointestinal melanoma (PGIM): a population-based study. Anticancer Res. 2021;41(2):967\u201374.","journal-title":"Anticancer Res"},{"issue":"8","key":"2254_CR35","first-page":"e16821","volume":"13","author":"NM Alsharif","year":"2021","unstructured":"Alsharif NM, Omeish H, Abdulelah M, Abu-Rumaileh MA, Bader H. Anorectal melanoma: an uncommon cause of lower gastrointestinal bleeding. Cureus. 2021;13(8):e16821.","journal-title":"Cureus"},{"issue":"2","key":"2254_CR36","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1200\/JCO.2016.67.9258","volume":"35","author":"SP D'Angelo","year":"2017","unstructured":"D\u2019Angelo SP, Larkin J, Sosman JA, Lebbe C, Brady B, Neyns B, Schmidt H, Hassel JC, Hodi FS, Lorigan P, et al. Efficacy and safety of Nivolumab alone or in combination with Ipilimumab in patients with mucosal melanoma: a pooled analysis. J Clin Oncol. 2017;35(2):226\u201335.","journal-title":"J Clin Oncol"},{"issue":"11","key":"2254_CR37","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1007\/s10147-020-01759-x","volume":"25","author":"Y Zheng","year":"2020","unstructured":"Zheng Y, Cong C, Su C, Sun Y, Xing L. Epidemiology and survival outcomes of primary gastrointestinal melanoma: a SEER-based population study. Int J Clin Oncol. 2020;25(11):1951\u20139.","journal-title":"Int J Clin Oncol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02254-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-022-02254-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02254-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T21:04:14Z","timestamp":1700427854000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-022-02254-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,9]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2254"],"URL":"https:\/\/doi.org\/10.1186\/s12876-022-02254-5","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,9]]},"assertion":[{"value":"17 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approved by the Wright Center for Graduate Medical Educational Institutional Review Board (WCGME-IRB). Our study is a retrospective study of human data and The Wright Center for Graduate Medical Education Institutional Review Board (WCGME-IRB) has waived the consent. All methods were carried out in relevant regulations and guidelines. IRB number: 1698777-1.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript, as submitted or its essence in another version, is not under consideration for publication elsewhere and will not be published elsewhere while under review by BMC Gastroenterology. All authors have made substantive contributions to the study, and all authors endorse the data and conclusions. All authors have no commercial associations (funding) or sources of support that might pose a conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"178"}}